. "Coagulopathy"@en . "Antimicrobial peptides"@en . "Consciousness"@en . "Thrombosis"@en . "Chromogranins"@en . "Pneumocytosis"@en . . "Humans"@en . . "ARDS"@en . "Inflammation"@en . "Oxidative stress"@en . . . "Hub disruption index"@en . "Diffuse alveolar hemorrhage"@en . "Inflammation Mediators"@en . "Machine learning"@en . "Nutrition & dietetics"@en . . "Critically ill patient"@en . "Mucormycosis"@en . "Topology"@fr . "Drug"@en . "Neuroimaging"@fr . "Lupus anticoagulant"@en . . . "Female"@en . "Preeclampsia"@en . "Connectomes"@en . "Lactate"@en . "Nitric Oxide Synthase Type II"@en . "Cyclooxygenase 2 Inhibitors"@en . "Cirrhosis"@en . "Liver transplantation"@en . "Vasculitis"@en . "Liver failure"@en . "Acute respiratory distress syndrome"@en . . . "Fungal"@en . "Connectome"@fr . . "Functional imaging"@en . "Vasoconstriction"@en . "Hypertension"@en . "Cell-Derived Microparticles"@en . "Epidemiology"@en . "Secretogranins"@en . "Coma"@en . "Nitric Oxide"@en . "NF-kappa B"@en . "Signal Transduction"@en . "Pre-Eclampsia"@en . . . . "Organ support"@en . "Critical care"@en . "ELISA"@en . "Prognostic"@en . "MRI"@en . "CGs"@en . "Intensive care"@en . "Morphine-6-glucuronide"@en . . . "Vascular inflammation"@en . . "Cyclooxygenase 2"@en . . "Dose-Response Relationship"@en . "Adult intensive & critical care"@en . "Diagnosis"@en . "Inflammatory myositis"@en . . . "Clinical trials"@en . . "Critical care patients"@en . . "Mortality"@en . . "COVID-19"@en . "Acute respiratory failure"@en . "Schneider" . . "Cardiogenic shock"@en . "Young Adult"@en . "Brain injury"@en . <0000-0002-7481-5101> . "Adult"@en . "Invasive fungal infections"@en . "Pregnancy"@en . "Consciousness disorders"@fr . "Francis Schneider" . "Omentum"@en . "Innate immunity"@en . "Candidemia"@en . . . "Vasoconstrictor Agents"@en . . "Tissue Culture Techniques"@en . "Aspergillosis"@en . . "Arteries"@en . "Interstitial lung disease"@en . "Cerebral mucormycosis"@en . "Francis" . . . "Graphs"@en . "Morphine"@en .